Sjögren's syndrome Flashcards
Define Sjögren’s syndrome
Systemic auto-immune exocrinopathy characterised by dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia)
Aetiology of Sjögren’s syndrome
Exact unknown
Due to lymphocytic infiltration into the lacrimal and salivary glands, as well as other exocrine glands therefore affecting the eyes, nose, mouth, vagina and larynx
HLA-A1, -B8, or -DR3/DQ2 thought to be linked
Associated with Anti-Ro and anti-La
Secondary: 60% have the disease secondary the rheumatoid arthritis, SLE or systemic sclerosis
Risk factors for Sjögren’s syndrome
Female
SLE, Rheumatoid arthritis, Systemic sclerosis
HLA class II markers
Family history
Epidemiology of Sjögren’s syndrome
Most common of all systemic auto-immune rheumatic diseases
Female:male ratio 9:1
Age peak after first menarche (20-30) and second after menopause (mid-50s)
Symptoms of Sjögren’s syndrome
Dry eyes:
- sensation of sand/gravel/itch/burning
- >3 months, multiple episodes a week
- Sensitivity to light and wind
Dry mouth: burning, enlarged salivary glands but no saliva
Dry nose
Fatigue: sleep disturbance, reduced physical capacity
Dry vagina → dyspareunia
Dry cough, dysphagia, heartburn
Vasculitis - skin rash, symptoms of polyarteritis nodosa
Dental caries (destruction around the necks of the teeth and on labial and incisal surfaces)
Alopecia
Memory and speech difficulties
Numbness in extremities (peripheral neuropathy)
Arthralgia and myalgia
Signs of Sjögren’s syndrome on examination
Dry eyes, corneal ulceration
Dry mouth, tongue
Enlarged salivary/parotid glands (bilateral)
Investigations for Sjögren’s syndrome
Schirmer’s test: positive (<5mm wet after 5 mins)
Urinalysis
Sialometry: decreased
Abs: anti-Ro(70%) and Anti-La (30%), rheumatoid factor (50%)
U&Es
Fluorescein corneal staining: 3 or more
Parotid sialography: gross distortion of normal parotid ductules + retention of contrast
Salivary gland scintigraphy: decreased uptake + secretion
Minor salivary gland biopsy: Focus score 1 or greater (increased cellular infiltrates)
Labial gland biopsy: Lymphocytic infiltration/aggregation (gold standard)
Skin biopsy: ? vasculitis
Angiography: ? vessel involvement
Management for Sjögren’s syndrome
Tear substitutes
Saliva substitutes
Pilocarpine (cholinergic agonist) to stimulate saliva
Analgesia: NSAIDs
Hydroxychloroquine and prednisolone (immunosuppression)
Requires specialist O&G management as Abs can cross placenta → heart block
Complications of Sjögren’s syndrome
Increased risk of Lymphoma (MALT)
Autoimmune thyroid disease, haemolytic anaemia, primary biliary cirrhosis
Impacts WOL: visual impairment, driving, reading, working, sleep
Anxiety and depression
Punctate epithelial erosions
Corneal scarring, thinning, ulceration, neovascularisation
Corneal infection or perforation
Prognosis for Sjögren’s syndrome
lifespan is generally not shortened
Dry eye disease is usually not curable but symptoms can generally be improved with treatment and modification of underlying causes